15 תוצאות
The subject matter of this application is related to that of our patent applications entitled "IMPROVED ANALGESIC COMPOSITIONS COMPRISING PROPIRAM METHODS 0F USING SAME" (Ser. No. 400,646 filed 7/22/82) and IMPROVED ANALGESTIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING IBUPROFEN AND METHODS OF
The subject matter of this application is related to that of our patent applications entitled "IMPROVED ANALGESIC COMPOSITIONS COMPRISING PROPIRAM AND METHODS OF USING SAME" and IMPROVED ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING IBUPROFEN AND METHODS OF USING SAME" filed concurrently
The subject matter of this application is related to that of our patent applications entitled "IMPROVED ANALGESIC COMPOSITIONS COMPRISING PROPIRAM AND METHODS OF USING SAME" Ser. No. 488,815 filed 4-26-83, now U.S. Pat. No. 4,479,956 and IMPROVED ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS
The subject matter of this application is related to that of our patent applications entitled "IMPROVED ANALGESIC COMPOSITIONS COMPRISING PROPIRAM AND METHODS OF USING SAME" (Attorney Docket No. 036430-002) and IMPROVED ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING IBUPROFEN AND METHODS OF
CROSS-REFERENCE TO RELATED APPLICATIONS
The subject matter of this application is related to that of our patent applications entitled "Improved Analgesic Compositions Comprising Propiram and Methods of Using Same" (Ser. No. 488,815) and "Improved Analgesic and Anti-inflammatory Compositions
BACKGROUND OF THE INVENTION
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglyean that are designed to be used as dietary
BACKGROUND OF THE INVENTION
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary
BACKGROUND OF THE INVENTION
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary
BACKGROUND OF THE INVENTION
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary
CROSS-REFERENCE TO RELATED APPLICATIONS
The subject matter of this application is related to that of our patent applications entitled "IMPROVED ANALGESIC COMPOSITIONS COMPRISING PROPIRAM AND METHODS OF USING SAME" and "IMPROVED ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING CAFFEINE AND
BACKGROUND
Caffeine is a central nervous system (CNS) stimulant belonging to the methylxanthine chemical class. It is the world's most widely consumed psychoactive drug. Caffeine affects several biological processes. The most prominent is reversibly blocking the action of adenosine on the adenosine
FIELD OF THE INVENTION
The present invention relates to the therapeutic use of toothpicks. More particularly, the present invention relates to toothpicks impregnated or coated with therapeutic agents such as zinc salts, vitamins, antioxidants, fluoride salts, and other medicaments. Most
BACKGROUND OF THE INVENTION
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary
FIELD OF THE INVENTION
The present invention relates to pharmaceutical compositions comprising analgesics, caffeine and vitamins and to methods of using the compositions to hasten the onset of an analgesic and/or anti-inflammatory response and to enhance an analgesic and/or anti-inflammatory
FIELD OF THE INVENTION
The present invention relates generally to the field of use of alkyl, alkoxyl, halogenyl, or hydroxyl substituted dicinnamoylquinides. Specifically, the present invention relates to the use of the above-mentioned compounds to treat diseases or conditions that improve from